EUVIMEDEUVIMED entdecken
Crossref

Risk factors associated with severity of acute radiation-induced skin injury (aRISI) in head and neck cancer — single-centre retrospective analysis with a review of the literature

Paweł Głuszak, Aleksandra Dańczak-Pazdrowska, Agnieszka Seraszek-Jaros, Joanna Kaźmierska, Jakub Pazdrowski

Reports of Practical Oncology and Radiotherapy · 30.07.2026

DOI: 10.5603/rpor.113776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 30.07.2026. Verfasst von Paweł Głuszak und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute radiation-induced skin injury (aRISI) is a frequent and clinically significant toxicity in patients with head and neck cancer (HNC) undergoing radiotherapy (RT). However, risk factors in this population remain unclear. We aimed to identify clinical and treatment-related predictors of severe aRISI and its onset. Materials and methods: We conducted a retrospective single-center cohort study of 251 consecutive HNC patients treated with definitive RT (2016–2024), with or without concurrent systemic therapy. The primary endpoint was severe aRISI (grade 3; Radiation Therapy Oncology Group scale). The secondary endpoint was time to first grade 1 aRISI. Logistic regression identified risk factors, while Kaplan–Meier and Cox models evaluated time-to-event outcomes.

Results

Grade 3 aRISI occurred in 84 patients (33%). Median time to grade 1 and grade 3 aRISI was 17 and 38 days, respectively. Multivariable analysis showed that female sex, poorer performance status, obesity, advanced nodal disease, and concurrent cetuximab were independently associated with severe aRISI. The strongest associations were observed for female sex (OR = 4.48, p < 0.001) and cetuximab (OR = 5.64, p = 0.014). Cetuximab was also linked to earlier onset of grade 1 aRISI compared with cisplatin or no systemic therapy. Age had a weak association with earlier onset, while smoking, diabetes, inflammatory markers, and cisplatin were not significant predictors.

Conclusions

Severe aRISI is common in HNC patients receiving RT. Clinical factors and cetuximab exposure may help identify high-risk patients for closer monitoring and preventive strategies. Prospective multicenter studies are needed to refine individualized risk prediction.

Zitieren

APA

Głuszak, P., Dańczak-Pazdrowska, A., Seraszek-Jaros, A., Kaźmierska, J., & Pazdrowski, J. (2026). Risk factors associated with severity of acute radiation-induced skin injury (aRISI) in head and neck cancer — single-centre retrospective analysis with a review of the literature. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.113776

Vancouver

Głuszak P, Dańczak-Pazdrowska A, Seraszek-Jaros A, Kaźmierska J, Pazdrowski J. Risk factors associated with severity of acute radiation-induced skin injury (aRISI) in head and neck cancer — single-centre retrospective analysis with a review of the literature. Reports of Practical Oncology and Radiotherapy. 2026. doi:10.5603/rpor.113776

BibTeX
@article{Guszak2026,
  author = {Głuszak, Paweł and Dańczak-Pazdrowska, Aleksandra and Seraszek-Jaros, Agnieszka and Kaźmierska, Joanna and Pazdrowski, Jakub},
  title = {Risk factors associated with severity of acute radiation-induced skin injury (aRISI) in head and neck cancer — single-centre retrospective analysis with a review of the literature},
  journal = {Reports of Practical Oncology and Radiotherapy},
  year = {2026},
  doi = {10.5603/rpor.113776}
}
Kostenlos starten →